| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |